U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
195241195241Bryostatin 1 In Treating Patients With Progressive Kidney CancerCompletedNo Results AvailableKidney CancerDrug: bryostatin 1https://ClinicalTrials.gov/show/NCT00005056
195242195242Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: glufosfamidehttps://ClinicalTrials.gov/show/NCT00005055
195243195243Temozolomide in Treating Women With Advanced Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: temozolomidehttps://ClinicalTrials.gov/show/NCT00005054
195244195244Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic CancerCompletedNo Results AvailablePancreatic CancerDrug: glufosfamidehttps://ClinicalTrials.gov/show/NCT00005053
195245195245Vaccine Therapy in Treating Patients With Primary Stage II MelanomaActive, not recruitingNo Results AvailableMelanoma (Skin)Biological: GM2-KLH vaccine|Biological: QS21|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00005052
195246195246Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial CancerCompletedNo Results AvailableOvarian CancerDrug: carboplatin|Drug: cisplatin|Drug: paclitaxel|Drug: topotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00005051
195247195247Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: ethynyluracil|Drug: fluorouracil|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00005050
195248195248Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal CancerCompletedNo Results AvailableColorectal Cancer|Gastric Cancer|Gastrointestinal Carcinoid Tumor|Gastrointestinal Stromal Tumor|Ovarian Cancer|Peritoneal Cavity Cancer|Small Intestine CancerDrug: carboplatin|Drug: cisplatin|Drug: floxuridinehttps://ClinicalTrials.gov/show/NCT00005049
195249195249Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNo Results AvailableProstate CancerDrug: estramustine phosphate sodium|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00005048
1952501952504B951, Combination Chemotherapy in Treating Patients With Bladder CancerActive, not recruitingNo Results AvailableBladder CancerDrug: cisplatin|Drug: doxorubicin hydrochloride|Drug: methotrexate|Drug: vinblastine|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00005047
195251195251Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal CancerCompletedNo Results AvailableOvarian Cancer|Primary Peritoneal Cavity CancerDrug: chemotherapy|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00005046
195252195252Carboxyamidotriazole in Treating Patients With Advanced Kidney CancerCompletedNo Results AvailableKidney CancerDrug: carboxyamidotriazolehttps://ClinicalTrials.gov/show/NCT00005045
195253195253Hormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerActive, not recruitingNo Results AvailableProstate CancerDrug: bicalutamide|Drug: flutamide|Drug: releasing hormone agonist therapy|Procedure: neoadjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00005044
195254195254SU5416 in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNo Results AvailableSarcomaDrug: semaxanibhttps://ClinicalTrials.gov/show/NCT00005042
195255195255R115777 in Treating Patients With Relapsed Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: tipifarnibhttps://ClinicalTrials.gov/show/NCT00005041
195256195256Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's LymphomaCompletedNo Results AvailableLymphomaDrug: arsenic trioxidehttps://ClinicalTrials.gov/show/NCT00005040
195257195257Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)TerminatedNo Results AvailableAdenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage IV Prostate CancerBiological: recombinant fowlpox-prostate specific antigen vaccine|Biological: recombinant vaccinia prostate-specific antigen vaccine|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00005039
195258195258Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney CancerActive, not recruitingNo Results AvailableKidney CancerBiological: aldesleukin|Drug: histamine dihydrochloridehttps://ClinicalTrials.gov/show/NCT00005038
195259195259Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: temozolomide|Drug: Temozolomidehttps://ClinicalTrials.gov/show/NCT00005037
195260195260Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNo Results AvailableMucinous Adenocarcinoma of the Colon|Mucinous Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Signet Ring Adenocarcinoma of the Colon|Signet Ring Adenocarcinoma of the Rectum|Stage IIIA Colon Cancer|Stage IIIA Rectal Cancer|StaDrug: irinotecan hydrochloride|Drug: oxaliplatin|Drug: leucovorin calcium|Drug: fluorouracil|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00005036
195261195261Oxaliplatin in Treating Patients With Advanced Head and Neck CancerCompletedNo Results AvailableHead and Neck CancerDrug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00005035
195262195262Trastuzumab in Treating Patients With Recurrent OsteosarcomaCompletedNo Results AvailableSarcomaBiological: trastuzumab|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00005033
195263195263Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung CancerCompletedNo Results AvailableLung CancerBiological: oblimersen sodium|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00005032
195264195264Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial CancerCompletedNo Results AvailableEndometrial CancerDrug: irofulvenhttps://ClinicalTrials.gov/show/NCT00005031
195265195265SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the LiverWithdrawnNo Results AvailableColorectal Cancer|Metastatic CancerDrug: SCH 66336|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00005030
195266195266Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal CancerTerminatedNo Results AvailableOvarian Cancer|Primary Peritoneal Cavity CancerDrug: topotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00005029
195267195267Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate CancerCompletedNo Results AvailableProstate CancerDrug: bryostatin 1|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00005028
195268195268Rebeccamycin Analog in Treating Patients With Advanced Kidney CancerCompletedNo Results AvailableKidney CancerDrug: becatecarinhttps://ClinicalTrials.gov/show/NCT00005027
195269195269Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerCompletedNo Results AvailableOvarian Cancer|Primary Peritoneal Cavity CancerDrug: carboplatin|Drug: paclitaxel|Drug: topotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00005026
195270195270Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal CancerActive, not recruitingNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity CancerBiological: herpes simplex thymidine kinase|Drug: ganciclovirhttps://ClinicalTrials.gov/show/NCT00005025

* Görseller ve İçerik tekif hakkına sahip olabilir